ASX
Botanix Pharmaceuticals
BOT:ASX•Healthcare
Sensitive ASX Announcement
Phase II Oral Calcitonin Positive Primary Endpoint CTX-I
Published: 01/08/07, 08:43am (AEST)•3 pages